Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 2
1998 5
1999 2
2000 1
2001 5
2002 10
2003 3
2004 8
2005 12
2006 13
2007 10
2008 7
2009 5
2010 11
2011 6
2012 4
2013 3
2014 3
2015 6
2016 6
2017 9
2018 8
2019 11
2020 10
2021 11
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

152 results
Results by year
Filters applied: . Clear all
Page 1
PCSK9 Activity Is Potentiated Through HDL Binding.
Burnap SA, Sattler K, Pechlaner R, Duregotti E, Lu R, Theofilatos K, Takov K, Heusch G, Tsimikas S, Fernández-Hernando C, Berry SE, Hall WL, Notdurfter M, Rungger G, Paulweber B, Willeit J, Kiechl S, Levkau B, Mayr M. Burnap SA, et al. Among authors: levkau b. Circ Res. 2021 Nov 12;129(11):1039-1053. doi: 10.1161/CIRCRESAHA.121.319272. Epub 2021 Oct 4. Circ Res. 2021. PMID: 34601896 Free PMC article.
S1PR1 on tumor-associated macrophages promotes lymphangiogenesis and metastasis via NLRP3/IL-1β.
Weichand B, Popp R, Dziumbla S, Mora J, Strack E, Elwakeel E, Frank AC, Scholich K, Pierre S, Syed SN, Olesch C, Ringleb J, Ören B, Döring C, Savai R, Jung M, von Knethen A, Levkau B, Fleming I, Weigert A, Brüne B. Weichand B, et al. Among authors: levkau b. J Exp Med. 2017 Sep 4;214(9):2695-2713. doi: 10.1084/jem.20160392. Epub 2017 Jul 24. J Exp Med. 2017. PMID: 28739604 Free PMC article.
Rivaroxaban Reduces Arterial Thrombosis by Inhibition of FXa-Driven Platelet Activation via Protease Activated Receptor-1.
Petzold T, Thienel M, Dannenberg L, Mourikis P, Helten C, Ayhan A, M'Pembele R, Achilles A, Trojovky K, Konsek D, Zhang Z, Regenauer R, Pircher J, Ehrlich A, Lüsebrink E, Nicolai L, Stocker TJ, Brandl R, Röschenthaler F, Strecker J, Saleh I, Spannagl M, Mayr CH, Schiller HB, Jung C, Gerdes N, Hoffmann T, Levkau B, Hohlfeld T, Zeus T, Schulz C, Kelm M, Polzin A. Petzold T, et al. Among authors: levkau b. Circ Res. 2020 Feb 14;126(4):486-500. doi: 10.1161/CIRCRESAHA.119.315099. Epub 2019 Dec 20. Circ Res. 2020. PMID: 31859592
Dapagliflozin reduces thrombin generation and platelet activation: implications for cardiovascular risk reduction in type 2 diabetes mellitus.
Kohlmorgen C, Gerfer S, Feldmann K, Twarock S, Hartwig S, Lehr S, Klier M, Krüger I, Helten C, Keul P, Kahl S, Polzin A, Elvers M, Flögel U, Kelm M, Levkau B, Roden M, Fischer JW, Grandoch M. Kohlmorgen C, et al. Among authors: levkau b. Diabetologia. 2021 Aug;64(8):1834-1849. doi: 10.1007/s00125-021-05498-0. Epub 2021 Jun 16. Diabetologia. 2021. PMID: 34131781 Free PMC article.
Sphingosine-1-phosphate: A mediator of the ARB-MI paradox?
Polzin A, Helten C, Dannenberg L, Müller T, Gräler M, Kelm M, Levkau B. Polzin A, et al. Among authors: levkau b. Int J Cardiol. 2021 Jun 15;333:40-42. doi: 10.1016/j.ijcard.2021.02.082. Epub 2021 Mar 4. Int J Cardiol. 2021. PMID: 33675892
Endothelial functions of sphingosine-1-phosphate.
Lucke S, Levkau B. Lucke S, et al. Among authors: levkau b. Cell Physiol Biochem. 2010;26(1):87-96. doi: 10.1159/000315109. Epub 2010 May 18. Cell Physiol Biochem. 2010. PMID: 20502008 Free article. Review.
MTX Treatment Does Not Improve Outcome in Mice with AMI.
Dannenberg L, Trojovsky K, Ayhan A, Helten C, Zako S, M'Pembele R, Mourikis P, Benkhoff M, Ignatov D, Sarabhai T, Petzold T, Huhn-Wientgen R, Zeus T, Kelm M, Levkau B, Polzin A. Dannenberg L, et al. Among authors: levkau b. Pharmacology. 2021;106(3-4):225-232. doi: 10.1159/000511279. Epub 2020 Nov 20. Pharmacology. 2021. PMID: 33221800
152 results